EMA approves 12 medicines including combined COVID-19 and influenza vaccine
EU Reporter —
At its February 2026 meeting, EMA’s human medicines committee (CHMP) recommended 12 medicines for approval, covering vaccines, innovative treatments and biosimilars, and issued two negative opinions. A major highlight was mCombriax, the first combined mRNA vaccine to protect adults aged 50 and over against both COVID-19 and seasonal influenza. With hundreds of millions of COVID-19 […]